Pancreatic Cancer Research

ResearcherUniversity of Electronic Science and Technology of ChinaActive in the last 2 years

Huiwen Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3626-6233; OpenAlex author ID A5069012173. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Letter to the Editor: a commentary on "Surgical treatment of synchronous liver-only oligometastatic pancreatic adenocarcinoma: a systematic review and meta-ana… Co-author DOI 10.1097/js9.0000000000002653↗
  2. A Commentary on "Long-term outcomes of upfront pancreatectomy with venous resection for pancreatic cancer: a single-center, retrospective analysis". Co-author DOI 10.1097/js9.0000000000004374↗
  3. Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis. Co-author DOI 10.1016/j.bbrc.2017.09.146↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Decai Wang · 1 shared paper, 2025 · strength 0.42
  2. Pei Yang · 1 shared paper, 2025 · strength 0.33
  3. Jianjun Wang · 1 shared paper, 2025 · strength 0.33
  4. Jun Pu · 1 shared paper, 2017 · strength 0.08
  5. Jianguo Lu · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.